Hong Kong launches first regional mediation platform for medical disputes

Hong Kong has unveiled the inaugural regional mediation and arbitration platform designed for medical and healthcare disputes, in a bid to streamline conflict resolution and bolster its position as a global legal services hub. The Healthcare Dispute Resolution Centre, a nonprofit organization established in 2024, unveiled its digital platform this past Friday, offering both virtual and in-person services for patients and medical professionals to settle disagreements through mediation and arbitration.

"We are tackling issues ranging from medical mistakes, patient rights violations, and contract problems which often escalate into protracted litigation that consumes time, finances, and vital resources," stated centre chairperson Samuel Kwok Po-yin. "With the growing cross-border utilization of medical services, our new website and platform will serve as the central hub for addressing medical and healthcare disputes in Hong Kong and the broader Greater Bay Area."

The Greater Bay Area encompasses Beijing's strategy to interlink Hong Kong, Macau, and the nine Guangdong cities into a formidable economic powerhouse. Kwok noted that mediation and arbitration typically prove faster, less expensive, and more confidential than court litigation, with cases handled through professional expertise. Currently, the Medical Council of Hong Kong manages most complaints against healthcare providers, concluding 263 cases by inquiry between 2020 and 2025.

Over 75% of these cases were resolved within five years, while 11 cases lingered for between 10 and 15 years.

The platform receives support from the eBRAM International Online Dispute Resolution Centre, a nonprofit entity backed by the Asian Academy of International Law, the Law Society of Hong Kong, and the Hong Kong Bar Association. It also draws backing from the Hong Kong International Medical Mediation Centre, which extends services through its 30 branch offices worldwide, including in mainland China, Singapore, and the United Kingdom.